Picture of Medexus Pharmaceuticals logo

MDP Medexus Pharmaceuticals News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Brief: Pediapharm Announces Q2 Revenue $3.1 Mln Versus $1.9 Mln

Nov 27 (Reuters) - Pediapharm Inc  PDP.V : 
    * PEDIAPHARM ANNOUNCES Q2 RECORD REVENUE AND FIRST-EVER 
ADJUSTED 
EBITDA POSITIVE QUARTER 
    * PEDIAPHARM INC - IN THREE-MONTH PERIOD ENDED SEPT 30, 
2017, 
QUARTERLY REVENUE OF $3.1 MILLION VERSUS $1.9 MILLION 
    * PEDIAPHARM INC - QTRLY NET LOSS AND COMPREHENSIVE LOSS 
$336,631 
VERSUS QTRLY NET LOSS AND COMPREHENSIVE LOSS OF $838,321 
 
Source text for Eikon:  ID:nCCNtRpl7a  
Further company coverage:  PDP.V  
 
 ((Bangalore.newsroom@thomsonreuters.com;;))

Recent news on Medexus Pharmaceuticals

See all news